SPRING 2024 ISSUE

Unveiling the Truth Behind Anti-Amyloid Monoclonal Antibodies in Alzheimer’s Disease Treatment

By Hamid Okhravi, MD
Alfred Abiouness Distinguished Professor of Geriatrics
Director, Goldrich Neurohealth Institute-Comprehensive Memory Center 
Glennan Center for Geriatrics and Gerontology

In this talk, Dr. Okhravi delved into the significance of anti-amyloid monoclonal antibodies in the treatment of Alzheimer’s disease (AD), exploring the veracity behind their efficacy. The discussion centered around three key antibodies: Aducanumab, Lecanemab, and Donanemab, providing a comprehensive review of their respective phase 3 clinical trials. He navigated through the evidence, evaluating the promise and potential pitfalls of each antibody in combating AD. Additionally, he explored the current landscape and near-future trajectory of clinical trial designs in AD treatment, shedding light on emerging trends and methodologies.

Furthermore, the talk addressed the real-world impacts of disease-modifying therapies in AD, probing into the requirements, challenges, and implications for clinical practice. By unraveling the complexities surrounding anti-amyloid monoclonal antibodies and their role in AD treatment, this presentation aimed to provide clarity and insight into the evolving landscape of Alzheimer’s therapeutics.

Share this content on social media!
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

APA Find a Psychiatrist

Are you accepting new patients?

Opt into APA’s Find A Psychiatrist database. To view the functionality or opt-in,
CLICK HERE

FYI: A link for this option has been added to the PSV websiteSelect the About button and then Find a Psychiatrist from the drop down.

GET PSV's NEW MEMBER APP!

Quick access to dues payment, meeting registration, member resources and more!

Capture the code with your mobile device or

As we move into 2024, ensure you have access to the tools you need to succeed by renewing your membership with the Psychiatric Society of Virginia/American Psychiatric Association.

We encourage you to visit the APA website for their convenient online dues payment system available HERE. If you need assistance with your member login, click HERE.

Save the Dates!

October 4-5, 2024
Hilton Richmond Downtown
Richmond, VA

Letters to the editor and editorial contributions are welcome. Submissions may be sent to Andrew Mann at [email protected]. Paid advertising is accepted on a first come, first served basis. Discounted advertising rates are available to PSV members. To place your advertisement or to request a rate sheet, contact Ray Hall at PSV Headquarters via email at [email protected] or by phone at (804) 565-6313.

© Psychiatric Society of Virginia
2209 Dickens Road | Richmond, VA 23230-2005 | Phone: (804) 565-6377 | Fax: (804) 282-0090 | Email: [email protected] | www.psva.org